scispace - formally typeset
G

Giuseppe Minniti

Researcher at University of Siena

Publications -  219
Citations -  10214

Giuseppe Minniti is an academic researcher from University of Siena. The author has contributed to research in topics: Radiation therapy & Radiosurgery. The author has an hindex of 50, co-authored 189 publications receiving 7617 citations. Previous affiliations of Giuseppe Minniti include Sapienza University of Rome & The Royal Marsden NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics

TL;DR: The cause‐effect relationship between GH/IGF‐I hypersecretion and precocious cardiovascular abnormalities in a series of young acromegalic patients is investigated.
Journal ArticleDOI

Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients.

TL;DR: It is concluded that SR-lanreotide is able to improve cardiac morphology and functional abnormalities in acromegaly; whether such beneficial effects on cardiac parameters will contribute to improve life expectancy in these patients should be further investigated.
Journal ArticleDOI

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

TL;DR: Concurrent SRS and ipilimumab or nivolumab show meaningful intracranial activity in patients with either asymptomatic and symptomatic melanoma brain metastases, although a subset of patients may develop symptomatic RN.
Journal ArticleDOI

Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients.

TL;DR: The aim of this prospective study was to investigate the effects of postoperative GH/IGF‐I normalization on echocardiographic parameters and blood pressure in a series of patients with active acromegaly.
Journal ArticleDOI

Modern techniques for pituitary radiotherapy

TL;DR: SCRT is a suitable treatment technique for all sizes of pituitary adenoma and efficacy is comparable to conventional RT; the lack of long term follow up means that currently there is no information on potential reduction in the incidence of late radiation induced toxicity.